Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tizanidine Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Tizanidine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 2mg Tablet
      • 1.3.3 4mg Tablet
      • 1.3.4 2mg Capsules
      • 1.3.5 4mg Capsules
      • 1.3.6 6mg Capsules
    • 1.4 Market Segment by Application
      • 1.4.1 Global Tizanidine Market Share by Application (2019-2025)
      • 1.4.2 Kids
      • 1.4.3 Adults
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Tizanidine Market Size
      • 2.1.1 Global Tizanidine Revenue 2014-2025
      • 2.1.2 Global Tizanidine Sales 2014-2025
    • 2.2 Tizanidine Growth Rate by Regions
      • 2.2.1 Global Tizanidine Sales by Regions 2014-2019
      • 2.2.2 Global Tizanidine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Tizanidine Sales by Manufacturers
      • 3.1.1 Tizanidine Sales by Manufacturers 2014-2019
      • 3.1.2 Tizanidine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Tizanidine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tizanidine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Tizanidine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Tizanidine Price by Manufacturers
    • 3.4 Key Manufacturers Tizanidine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Tizanidine Market
    • 3.6 Key Manufacturers Tizanidine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 2mg Tablet Sales and Revenue (2014-2019)
      • 4.1.2 4mg Tablet Sales and Revenue (2014-2019)
      • 4.1.3 2mg Capsules Sales and Revenue (2014-2019)
      • 4.1.4 4mg Capsules Sales and Revenue (2014-2019)
      • 4.1.5 6mg Capsules Sales and Revenue (2014-2019)
    • 4.2 Global Tizanidine Sales Market Share by Type
    • 4.3 Global Tizanidine Revenue Market Share by Type
    • 4.4 Tizanidine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Tizanidine Sales by Application

    6 United States

    • 6.1 United States Tizanidine Breakdown Data by Company
    • 6.2 United States Tizanidine Breakdown Data by Type
    • 6.3 United States Tizanidine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Tizanidine Breakdown Data by Company
    • 7.2 European Union Tizanidine Breakdown Data by Type
    • 7.3 European Union Tizanidine Breakdown Data by Application

    8 China

    • 8.1 China Tizanidine Breakdown Data by Company
    • 8.2 China Tizanidine Breakdown Data by Type
    • 8.3 China Tizanidine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Tizanidine Breakdown Data by Company
    • 9.2 Rest of World Tizanidine Breakdown Data by Type
    • 9.3 Rest of World Tizanidine Breakdown Data by Application
    • 9.4 Rest of World Tizanidine Breakdown Data by Countries
      • 9.4.1 Rest of World Tizanidine Sales by Countries
      • 9.4.2 Rest of World Tizanidine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Actavis
      • 10.1.1 Actavis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Tizanidine
      • 10.1.4 Tizanidine Product Introduction
      • 10.1.5 Actavis Recent Development
    • 10.2 Teva
      • 10.2.1 Teva Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Tizanidine
      • 10.2.4 Tizanidine Product Introduction
      • 10.2.5 Teva Recent Development
    • 10.3 Sandoz
      • 10.3.1 Sandoz Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Tizanidine
      • 10.3.4 Tizanidine Product Introduction
      • 10.3.5 Sandoz Recent Development
    • 10.4 Acorda
      • 10.4.1 Acorda Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Tizanidine
      • 10.4.4 Tizanidine Product Introduction
      • 10.4.5 Acorda Recent Development
    • 10.5 Unichem Laboratories
      • 10.5.1 Unichem Laboratories Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Tizanidine
      • 10.5.4 Tizanidine Product Introduction
      • 10.5.5 Unichem Laboratories Recent Development
    • 10.6 APOTEX
      • 10.6.1 APOTEX Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Tizanidine
      • 10.6.4 Tizanidine Product Introduction
      • 10.6.5 APOTEX Recent Development
    • 10.7 Sun Pharmaceutical
      • 10.7.1 Sun Pharmaceutical Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Tizanidine
      • 10.7.4 Tizanidine Product Introduction
      • 10.7.5 Sun Pharmaceutical Recent Development
    • 10.8 CorePharma
      • 10.8.1 CorePharma Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Tizanidine
      • 10.8.4 Tizanidine Product Introduction
      • 10.8.5 CorePharma Recent Development
    • 10.9 Dr. Reddy's Laboratories
      • 10.9.1 Dr. Reddy's Laboratories Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Tizanidine
      • 10.9.4 Tizanidine Product Introduction
      • 10.9.5 Dr. Reddy's Laboratories Recent Development
    • 10.10 Mylan
      • 10.10.1 Mylan Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Tizanidine
      • 10.10.4 Tizanidine Product Introduction
      • 10.10.5 Mylan Recent Development
    • 10.11 Oxford PharmaGenesis
    • 10.12 Niche Generics Limited
    • 10.13 CREDIT PHARMA
    • 10.14 YABANG

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Tizanidine Sales Channels
      • 11.2.2 Tizanidine Distributors
    • 11.3 Tizanidine Customers

    12 Market Forecast

    • 12.1 Global Tizanidine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Tizanidine Sales Forecast by Type
    • 12.3 Global Tizanidine Sales Forecast by Application
    • 12.4 Tizanidine Forecast by Regions
      • 12.4.1 Global Tizanidine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Tizanidine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
      In 2019, the market size of Tizanidine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tizanidine.

      This report studies the global market size of Tizanidine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Tizanidine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Actavis
      Teva
      Sandoz
      Acorda
      Unichem Laboratories
      APOTEX
      Sun Pharmaceutical
      CorePharma
      Dr. Reddy's Laboratories
      Mylan
      Oxford PharmaGenesis
      Niche Generics Limited
      CREDIT PHARMA
      YABANG

      Market Segment by Product Type
      2mg Tablet
      4mg Tablet
      2mg Capsules
      4mg Capsules
      6mg Capsules

      Market Segment by Application
      Kids
      Adults

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Tizanidine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Tizanidine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Tizanidine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now